CTLA4 and metastatic melanoma: The humanized anti-CTLA-4 monoclonal antibody, Ipilimumab (Yervoy), is currently used to treat advanced metastatic melanoma.Furthermore, it’s important to note that CTLA-4, while expressed on Tregs, also has implications for conventional T cells.